The Chromosome 9p21 CVD- and T2D-Associated Regions in a Norwegian Population (The HUNT2 Survey)

Table 1

Clinical characteristic of the 5564 subjects included in the study and eligible for analysis.

	All	T2D	AP	MI	Stroke	No T2D and/or CVD
Individuals ()	5,564	1,590^a	769^a	672^a	500^a	3,027^a
Gender (male/female)	2,754/2,810	754/836	435/334	475/197	256/244	1,424/1,603
Age (years at examination)
BMI (kg/m^2)
Ever smoked (yes/no)	2,600/2,964	647/943	345/424	367/305	241/259	1,468/1,559
Nonfasting serum glucose^b (mmol/L)
Serum triglyceride (mmol/L)
Serum cholesterol (mmol/L)
Serum HDL cholesterol (mmol/L)
Heart rate (bpm)
Type 2 diabetes (, %)	1,590 (28.6%)	1,590 (100%)	326 (42.4%)	212 (31.5%)	110 (22%)	n/a
Myocardial infarction (, %)	672 (12.1%)	212 (13.3%)	357 (46.9%)	672 (100%)	83 (16.6%)	n/a
Stroke (, %)	500 (9.0%)	110 (6.9%)	115 (15.1%)	357 (53.1%)	500 (100%)	n/a
Angina pectoris (, %)	769 (13.7%)	326 (20.5%)	769 (100%)	83 (12.4%)	115 (23%)	n/a

Values are presented as means ± SD or number (%). ^aSome individuals have more than one outcome (for example MI + diabetes); hence, the sum of these column counts does not match the total counts of individuals. ^bOnly nonfasting glucose measures were available for participants in the HUNT2 cohort. MI denotes previous myocardial infarction. Abbreviations: T2D, Type 2 diabetes; AP, angina pectoris; MI, myocardial infarction; CVD, cardiovascular disease; bpm, beats per minute.